1. Product Overview
2. Research Methodology
3.
Executive Summary
4. Voice of Customer
4.1.
Brand Awareness
4.2.
Factors Affecting Purchase Decision
4.3.
Product Preference, By Therapeutics
5. Impact of COVID-19
on Global Gynecology
Drugs Market
6. Global Gynecology Drugs Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1.
By Therapeutics (Non-Hormonal
Therapy vs Hormonal Therapy)
6.2.2.
By Indication (Contraception, Gynecology infections, Female infertility,
Postmenopausal Disorders, Polycystic Ovary Syndrome, Gynecology Cancer, Endometriosis)
6.2.3.
By Distribution Channel (Retail Pharmacies, Hospital Pharmacies Online
Pharmacies)
6.2.4. By Region (North
America, Europe, Asia Pacific, South America, Middle East & Africa)
6.2.5. By Company (2021)
6.3.
Product Market Map
7. North America Gynecology Drugs Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Therapeutics
7.2.2. By Indication
7.2.3. By Distribution
Channel
7.2.4. By Country
7.3.
North America: Country Analysis
7.3.1. United States Gynecology Drugs Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Therapeutics
7.3.1.2.2.
By Indication
7.3.1.2.3.
By Distribution Channel
7.3.2. Canada Gynecology Drugs Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Therapeutics
7.3.2.2.2.
By Indication
7.3.2.2.3.
By Distribution Channel
7.3.3. Mexico Gynecology Drugs Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Therapeutics
7.3.3.2.2.
By Indication
7.3.3.2.3.
By Distribution Channel
8. Europe Gynecology Drugs Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Therapeutics
8.2.2. By Indication
8.2.3. By Distribution
Channel
8.2.4. By Country
8.3.
Europe: Country Analysis
8.3.1. Germany Gynecology Drugs Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Therapeutics
8.3.1.2.2.
By Indication
8.3.1.2.3.
By Distribution Channel
8.3.2. France Gynecology Drugs Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Therapeutics
8.3.2.2.2.
By Indication
8.3.2.2.3.
By Distribution Channel
8.3.3. United Kingdom Gynecology Drugs Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Therapeutics
8.3.3.2.2.
By Indication
8.3.3.2.3.
By Distribution Channel
8.3.4. Italy Gynecology Drugs Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Therapeutics
8.3.4.2.2.
By Indication
8.3.4.2.3.
By Distribution Channel
8.3.5. Spain Gynecology Drugs Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Therapeutics
8.3.5.2.2.
By Indication
8.3.5.2.3.
By Distribution Channel
9.
Asia Pacific Gynecology Drugs Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Therapeutics
9.2.2. By Indication
9.2.3. By Distribution Channel
9.2.4. By Country
9.3.
Asia Pacific: Country Analysis
9.3.1. China Gynecology Drugs Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Therapeutics
9.3.1.2.2.
By Indication
9.3.1.2.3.
By Distribution Channel
9.3.2. Japan Gynecology Drugs Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Therapeutics
9.3.2.2.2.
By Indication
9.3.2.2.3.
By Distribution Channel
9.3.3. India Gynecology Drugs Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Therapeutics
9.3.3.2.2.
By Indication
9.3.3.2.3.
By Distribution Channel
9.3.4. Australia Gynecology Drugs Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Therapeutics
9.3.4.2.2.
By Indication
9.3.4.2.3.
By Distribution Channel
9.3.5. South Korea Gynecology Drugs Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Therapeutics
9.3.5.2.2.
By Indication
9.3.5.2.3.
By Distribution Channel
10. South America Gynecology Drugs Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Therapeutics
10.2.2. By Indication
10.2.3. By Distribution
Channel
10.2.4. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Gynecology Drugs Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Therapeutics
10.3.1.2.2.
By Indication
10.3.1.2.3.
By Distribution Channel
10.3.2. Argentina Gynecology Drugs Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Therapeutics
10.3.2.2.2.
By Indication
10.3.2.2.3.
By Distribution Channel
10.3.3. Colombia Gynecology Drugs Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Therapeutics
10.3.3.2.2.
By Indication
10.3.3.2.3.
By Distribution Channel
11. Middle East and
Africa Gynecology
Drugs Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Therapeutics
11.2.2. By Indication
11.2.3. By Distribution
Channel
11.2.4. By Country
11.3.
Middle East and Africa: Country Analysis
11.3.1. South Africa Gynecology Drugs Market Outlook
11.3.1.1. Market Size &
Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share &
Forecast
11.3.1.2.1.
By Therapeutics
11.3.1.2.2.
By Indication
11.3.1.2.3.
By Distribution Channel
11.3.2. Saudi Arabia Gynecology Drugs Market Outlook
11.3.2.1. Market Size &
Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share &
Forecast
11.3.2.2.1.
By Therapeutics
11.3.2.2.2.
By Indication
11.3.2.2.3.
By Distribution Channel
11.3.3. UAE Gynecology Drugs Market Outlook
11.3.3.1. Market Size &
Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share &
Forecast
11.3.3.2.1.
By Therapeutics
11.3.3.2.2.
By Indication
11.3.3.2.3.
By Distribution Channel
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends and
Developments
14. Competitive
Landscape
14.1.
Company
profiles
14.1.1. Eli Lilly and
Company Ltd.
14.1.2. Pfizer Inc.
14.1.3. Merck & Co.,
Inc.
14.1.4. Amgen Inc.
14.1.5. AstraZeneca Plc
14.1.6. F. Hoffmann-La Roche
Ltd.
14.1.7. Allergan Plc.
14.1.8. Bayer AG
14.1.9. Abbott Laboratories
Ltd.
14.1.10. AbbVie Inc.
14.1.11. GlaxoSmithKline Plc
14.1.12. Novartis Ltd.
14.1.13.
Lupin Pharmaceuticals, Inc.
14.1.14.
Johnson and Johnson Inc.
14.1.15.
Sanofi SA
15. Strategic
Recommendations
16. About Us & Disclaimer
Figure 1: Global Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 2: Global Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 3: Global Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 4: Global Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 5: Global Gynecology Drugs Market Share, By Region, By Value, 2017-2027F
Figure 6: Global Gynecology Drugs Market Share, By Company, By Value, 2021
Figure 7: Global Gynecology Drugs Market Map, By Therapeutics, Market Size (USD Million) & Growth Rate (%), 2021
Figure 8: Global Gynecology Drugs Market Map, By Indication, Market Size (USD Million) & Growth Rate (%), 2021
Figure 9: Global Gynecology Drugs Market Map, By Distribution Channel, Market Size (USD Million) & Growth Rate (%), 2021
Figure 10: Global Gynecology Drugs Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
Figure 11: North America Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 12: North America Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 13: North America Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 14: North America Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 15: North America Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
Figure 16: United States Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 17: United States Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 18: United States Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 19: United States Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 20: Canada Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 21: Fertility Rate in Canada, 2005, 2010, 2015, 2020
Figure 22: Canada Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 23: Canada Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 24: Canada Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 25: Mexico Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 26: Mexico Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 27: Mexico Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 28: Mexico Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 29: Europe Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 30: Europe Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 31: Europe Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 32: Europe Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 33: Europe Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
Figure 34: Germany Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 35: Fertility Rate in Germany, 2005, 2010, 2015, 2020
Figure 36: Germany Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 37: Germany Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 38: Germany Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 39: France Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 40: France Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 41: France Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 42: France Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 43: United Kingdom Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 44: Prevalence of Menopause Symptoms Experienced by Women at Work in United Kingdom, 2021
Figure 45: United Kingdom Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 46: United Kingdom Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 47: United Kingdom Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 48: Italy Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 49: Fertility Rate in Italy, 2005, 2010, 2015, 2020
Figure 50: Italy Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 51: Italy Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 52: Italy Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 53: Spain Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 54: Spain Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 55: Spain Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 56: Spain Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 57: Asia Pacific Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 58: Asia Pacific Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 59: Asia Pacific Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 60: Asia Pacific Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 61: Asia Pacific Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
Figure 62: China Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 63: China Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 64: China Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 65: China Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 66: Japan Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 67: Estimated Share of Women in Japan Using any Contraceptive Method, 2005, 2010, 2015, 2020
Figure 68: Japan Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 69: Japan Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 70: Japan Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 71: India Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 72: Polycystic Ovary Syndrome Issues Among Women Across India, By Age Group, 2020
Figure 73: India Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 74: India Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 75: India Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 76: Australia Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 77: Australia Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 78: Australia Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 79: Australia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 80: South Korea Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 81: South Korea Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 82: South Korea Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 83: South Korea Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 84: South America Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 85: South America Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 86: South America Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 87: South America Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 88: South America Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
Figure 89: Brazil Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 90: Fertility Rate in Brazil, 2005, 2010, 2015, 2020
Figure 91: Brazil Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 92: Brazil Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 93: Brazil Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 94: Argentina Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 95: Total Female Population of Argentina, by Age Group, 2020 (in Millions)
Figure 96: Argentina Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 97: Argentina Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 98: Argentina Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 99: Colombia Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 100: Colombia Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 101: Colombia Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 102: Colombia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 103: Middle East & Africa Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 104: Middle East & Africa Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 105: Middle East & Africa Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 106: Middle East & Africa Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 107: Middle East & Africa Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
Figure 108: South Africa Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 109: Fertility Rate in South Africa, 2005, 2010, 2015, 2020
Figure 110: South Africa Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 111: South Africa Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 112: South Africa Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 113: Saudi Arabia Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 114: Saudi Arabia Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 115: Saudi Arabia Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 116: Saudi Arabia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 117: UAE Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 118: Total Female Population of UAE, by Age Group, 2020 (in Millions)
Figure 119: UAE Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 120: UAE Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 121: UAE Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
List of Tables:
Table 1: Infertility Statistics of United States
Table 2: Ovary Cancer Cases in Mexico, 2020
Table 3: Ovary Cancer Cases in France, 2020
Table 4: Ovary Cancer Cases in Spain, 2020
Table 5: Ovary Cancer Cases in China, 2020
Table 6: Cancer Statistics of Australia, 2020
Table 7: Ovary Cancer Cases in South Korea, 2020
Table 8: Ovary Cancer Cases in Colombia, 2020
Table 9: Cervix Uteri Cancer Cases in Saudi Arabia, 2020